Funding for research interventions to reduce liver disease and cancer disparities in at-risk U.S. populations, with simplified review criteria.
Funder: National Institutes of Health
Due Dates: February 5, 2027 (New) | March 5, 2027 (Resubmission) | June 5, 2027 (New) | July 5, 2027 (Resubmission) | January 7, 2028 (Closing)
Funding Amounts: Budgets based on project needs, up to 5 years; NCI will not consider proposals greater than $500,000
Summary: Supports multi-level and/or multi-domain interventions to reduce liver disease and liver cancer disparities in U.S. populations experiencing health disparities.
Key Information: Only new and resubmission applications are accepted; clinical trials are optional.
This NIH R01 initiative supports the development and testing of multidisciplinary, multi-level and/or multi-domain interventions to reduce disparities in liver diseases and liver cancer. Participating institutes are the National Institute on Minority Health and Health Disparities (NIMHD), National Institute on Alcohol Abuse and Alcoholism (NIAAA), and National Cancer Institute (NCI). The program focuses on screening, prevention, treatment, management, and survivorship among U.S. populations experiencing health disparities.
Projects should be community-engaged and address multiple socioecological levels or domains. Research interests include hepatitis B vaccination, hepatitis B and C care and treatment, metabolic dysfunction-associated steatotic liver disease, chronic liver disease, and liver cancer. Interventions addressing social determinants of health, substance use, environmental exposures, comorbidities, family influences, and protective factors are encouraged. Natural experiments and interventions addressing risk factors before progression to chronic conditions are also of interest.